INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Lyophilization To Enable Drug Products Containing Labile Molecules
Develop lyophilized formulations to overcome stability challenges and significantly extend the shelf life of sensitive therapeutic products.
-
The Challenges Of Developing Combination Products
Examine the regulatory complexity of combination products and learn how holistic development strategies, early equipment decisions, and representative clinical supply reduce risk and costs.
-
What Does Annex 1 Mean For Cryovial Filling?
New sterile manufacturing rules require major changes to cryovial filling. Ensure compliance by adopting better "first-air" protection, minimizing human contact, and using 100% dose checks.
-
Water For Injection: Strategic Utility And The Case For Outsourcing
Water for Injection is a critical, highly regulated component of sterile drug manufacturing. Outsourcing its production offers faster timelines, reduced risk, and improved operational and cost efficiency.
-
Navigating The New USP Chapter <382> For Elastomeric Closures6/24/2025
Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape, which includes new required tests, instrumentation for compliance, and recommendations on implementation.
-
How Asia and Europe Are Reshaping Biologics Manufacturing4/9/2026
As biologics manufacturing globalizes, companies must balance cost, capacity, risk, and control when choosing between European and Asian supply bases for clinical and commercial success.
-
Solutions In Pre-Filled Syringes For Biologics And Ophthalmic Applications6/19/2025
Discover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.
-
Efficient, Single-Source PFS Supply5/21/2026
When component lead times don’t align, inventory piles up, cash gets tied up, and forecasts can quickly turn into waste or shortages. What if a single integrated PFS system could simplify it all?
-
Ensuring Consistent Quality In Pharmaceutical Water For Injection (WFI) Systems Presentation3/5/2026
Maintaining high-purity water is vital for pharmaceutical production. Explore key strategies for system design, risk mitigation, and rigorous process control to ensure consistent regulatory compliance.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
CAP-IS (Compact Aseptic Processing Isolator System) is a cGMP Class A/ISO 5 isolation system, specifically designed for pharmaceutical production laboratories.
-
The aseptic/sterile Fill-Finish equipment solutions need to be cGMP compliant, dependable and accurately designed to comply with the most recent revisions of the “Annex 1 Manufacture of Sterile Medicinal Products guidelines”. Newly designed equipment needs to accommodate for small batches, various speeds and containers, including RTU / RTF (Ready To Use or Ready To Fill) bottles, vials, cartridges, syringes and pre-sterile nested trays. Moreover, the filling equipment solution should also improve the ergonomic use for operators and maximize cleanroom efficiency.
-
Microbial monitoring is an important part of proving a manufacturing process is under control, especially in aseptic production. Explore solutions for the microbial monitoring of aseptic pharmaceutical manufacturing.
-
DCS® Liquid was specifically developed for toxic and corrosive liquids, achieving containment levels of < 1 ppb. The safe and contained emptying and filling of drums is thus made possible without additional precautions, such as full protective clothing or large laminar airflow booths.
-
Explore process liquids preparation services and custom solutions for biopharmaceutical manufacturers.